All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Feasibility of atlas-based active bone marrow sparing intensity modulated radiation therapy for cervical cancer

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00179906%3A_____%2F17%3A10367303" target="_blank" >RIV/00179906:_____/17:10367303 - isvavai.cz</a>

  • Result on the web

    <a href="http://dx.doi.org/10.1016/j.radonc.2017.02.017" target="_blank" >http://dx.doi.org/10.1016/j.radonc.2017.02.017</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1016/j.radonc.2017.02.017" target="_blank" >10.1016/j.radonc.2017.02.017</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Feasibility of atlas-based active bone marrow sparing intensity modulated radiation therapy for cervical cancer

  • Original language description

    Background: To test the hypothesis that atlas-based active bone marrow (ABM) -sparing intensity modulated radiation therapy (IMRT) yields similar dosimetric results compared to custom ABM-sparing IMRT for cervical cancer patients. Methods: We sampled 62 cervical cancer patients with pre-treatment FDG-PET/CT in training (n = 32) or test (n = 30) sets. ABM was defined as the subvolume of the pelvic bone marrow (PBM) with standardized uptake value (SUV) above the mean on the average FDG-PET image (ABM(Atlas)) vs the individual&apos;s PET (ABM(custom)). Both were deformed to the planning CI&apos;. Overlap between the two subvolumes was measured using the Dice coefficient. Three IMRT plans designed to spare PBM, ABM(Atlas), or ABM(custom) were compared for 30 test patients. Dosimetric parameters were used to evaluate plan quality. Results: ABM(Atlas) and ABM(custom) volumes were not significantly different (p = 0.90), with a mean Dice coefficient of 0.75, indicating good agreement. Compared to IMRT plans designed to spare PBM and ABM(custom), ABM(Atlas)-Sparing IMRT plans achieved excellent target coverage and normal tissue sparing, without reducing dose to ABMcustom, (mean ABM(custom) dose 29.4 Gy vs. 27.1 Gy vs. 26.9 Gy, respectively; p = 0.10); however, PTV coverage and bowel sparing were slightly reduced. Conclusions: Atlas-based ABM sparing IMRT is clinically feasible and may obviate the need for customized ABM-sparing as a strategy to reduce hematologic toxicity.

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database

  • CEP classification

  • OECD FORD branch

    30204 - Oncology

Result continuities

  • Project

  • Continuities

    I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Others

  • Publication year

    2017

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Radiotherapy and Oncology

  • ISSN

    0167-8140

  • e-ISSN

  • Volume of the periodical

    123

  • Issue of the periodical within the volume

    2

  • Country of publishing house

    NL - THE KINGDOM OF THE NETHERLANDS

  • Number of pages

    6

  • Pages from-to

    325-330

  • UT code for WoS article

    000403028800025

  • EID of the result in the Scopus database

    2-s2.0-85019613782